Is the drug pipeline really drying up?
This week we’ll hear why Donald Light, professor of comparative health systems research at the University of Medicine and Dentistry of New Jersey, thinks the innovation crisis in the development of drugs is more marketing rhetoric than reality.
Also this week, a research paper on bmj.com looks at how subclinical psychological distress affects mortality. Tom Russ, Alzheimer Scotland clinical research fellow at the University of Edinburgh and one of the paper's authors, explains what they found.
See also
Association between psychological distress and mortality
Pharmaceutical research and development: what do we get for all that money?
Audio chapters:
Psychological distress and mortality: 0:37
Innovation crisis: 9:34








Total cost of overdiagnosis is probably 50 times higher than modelled here
Published 21 May 2013
Re: Antibiotics for back pain: hope or hype?
Published 21 May 2013
Re: Are antidepressants overprescribed? No
Published 21 May 2013
UGC India and MCI should lower the beam for a while for teachers in FAMILY MEDICINE, to let it come up as a different entity taught by specialists from FAMILY MEDICINE only
Published 21 May 2013